3
Announcements
Trials
Browse
Landscape
Status
Completed
9
Not yet recruiting
5
Recruiting
4
Unknown
3
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Tobacco Smoking
1
Stomach Neoplasms
1
Smoking Cessation
1
Smoking
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myocarditis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Burkitt Lymphoma
1
Interventions
Carboplatin
49
Pemetrexed
38
Cisplatin
34
Radiotherapy
32
Docetaxel
31
Gemcitabine
25
Paclitaxel
24
Nivolumab
18
pembrolizumab
15
Etoposide
15
Radiosurgery
13
Erlotinib Hydrochloride
11
Bevacizumab
11
Magnetic Resonance Spectroscopy
10
Vinorelbine
9
Radiation
9
Cyclophosphamide
7
durvalumab
6
Gefitinib
6
Fluorodeoxyglucose F18
6
Celecoxib
6
atezolizumab
5
Oxaliplatin
5
Irinotecan
5
Immunoglobulin G
5
Drug Therapy
5
Disulfides
5
Dexamethasone
5
Chemotherapy, Adjuvant
5
vandetanib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Lung Neoplasms
×
Tomography, X-Ray Computed
×
Clear all
NCT04282694
2021-11-19
PSP
University of Parma
Terminated
9 enrolled